TriSalus Life Sciences, Inc. (TLSI) Ownership

NASDAQ: TLSITop holders, insider trades and short interest.

TLSI ownership summary

as of October 18, 2026
Institutions
35.7%
of shares outstanding
Insiders
33.96%
of shares outstanding
Shares outstanding
61.6M
Float
49.8M
shares available to trade
Short interest
7.17%
3.3M shares short
Days to cover
7.57
short interest up 0.0% vs prior month
  • Institutions 35.72%
  • Insiders 33.96%
  • Other investors 30.32%

TLSI top institutional holders

20 largest
TriSalus Life Sciences, Inc. top institutional holders
#Holder% of sharesSharesValueChangeReported
1First Light Asset Management, LLC10.64%6.6M$23.8M+1.5M (+29.3%)June 30, 2026
2BlackRock Inc4.32%2.7M$9.7M+1.2M (+77.3%)June 30, 2026
3Nantahala Capital Management, LLC3.25%2.0M$7.3M−70,827 (−3.4%)June 30, 2026
4Vanguard Capital Management, LLC2.81%1.7M$6.3M+382,349 (+28.4%)June 30, 2026
5HPM Partners LLC2.60%1.6M$5.8M+816,266 (+103.7%)June 30, 2026
6Geode Capital Management, LLC1.93%1.2M$4.3M+412,973 (+53.1%)June 30, 2026
7Gilder Gagnon Howe & CO LLC1.38%850K$3.1M−38,434 (−4.3%)June 30, 2026
8State Street Corp0.99%611K$2.2M+282,943 (+86.3%)June 30, 2026
9White Pine Capital LLC0.89%548K$2.0M+183,922 (+50.6%)June 30, 2026
10Thompson, Siegel & Walmsley LLC0.87%537K$1.9M−47,040 (−8.1%)June 30, 2026
11Kennedy Capital Management Inc0.77%476K$1.7M−8,981 (−1.9%)June 30, 2026
12Morgan Stanley - Brokerage Accounts0.65%402K$1.5M+7,905 (+2.0%)June 30, 2026
13Northern Trust Corp0.62%380K$1.4M+158,099 (+71.4%)June 30, 2026
14Vanguard Portfolio Management, LLC0.54%329K$1.2M+164,606 (+99.8%)June 30, 2026
15Vanguard Fiduciary Trust Co0.52%321K$1.2M+102,604 (+47.0%)June 30, 2026
16Lionhunter Capital Management, LLC0.49%300K$1.1M+300,275 (0.0%)June 30, 2026
17Perkins Capital Management Inc0.38%235K$853,417+5,000 (+2.2%)June 30, 2026
18UBS Group AG0.36%223K$809,661+143,495 (+180.4%)June 30, 2026
19Bank of America Corp0.33%205K$745,391+3,623 (+1.8%)June 30, 2026
20Royce & Associates, LP0.32%200K$726,218—June 30, 2026

Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 15 holders added 5.6M shares and 4 cut 165K.

TLSI top mutual fund and ETF holders

18 largest
TriSalus Life Sciences, Inc. top fund holders
#Holder% of sharesSharesValueChangeReported
1Vanguard MStar Total Stk Mkt Idx Invest1.85%1.1M$4.1M—August 31, 2026
2iShares Russell 2000 ETF1.82%1.1M$4.1M−12,928 (−1.1%)September 30, 2026
3Fidelity Small Cap Index0.85%522K$1.9M+2,392 (+0.5%)July 31, 2026
4iShares Russell 2000 Growth ETF0.68%420K$1.5M−531 (−0.1%)September 30, 2026
5Vanguard Russell 2000 ETF0.42%257K$931,447−18,033 (−6.6%)September 30, 2026
6Fidelity Extended Market Index0.38%234K$848,955−1,257 (−0.5%)August 31, 2026
7Royce Small-Cap Growth Growth Svc0.32%200K$726,000—September 30, 2026
8iShares Micro-Cap ETF0.23%140K$507,605−964 (−0.7%)September 30, 2026
9Schwab Small Cap Index0.19%117K$423,508—August 31, 2026
10iShares Russell 2000 Small-Cap Idx Instl0.15%90K$325,277—August 31, 2026
11Fidelity Total Market Index0.14%86K$310,383+2,132 (+2.6%)August 31, 2026
12Fidelity Series Total Market Index0.12%73K$265,291+4,778 (+7.0%)August 31, 2026
13EA Bridgeway Ultra-Small Company Mkt ETF0.10%64K$232,777—September 30, 2026
14Nuveen Small Cap Blend Idx R60.10%64K$231,950—August 31, 2026
15Goldman Sachs Absolute Ret Trckr Instl0.09%56K$203,683+30,550 (+119.5%)June 30, 2026
16EQ/2000 Managed Volatility IB0.08%49K$179,652—August 31, 2026
17Vanguard Russell 2000 Growth ETF0.08%48K$174,922−3,937 (−7.6%)September 30, 2026
18Fidelity Small Cap Growth Index0.08%47K$171,677+2,602 (+5.8%)July 31, 2026

Funds report holdings monthly or quarterly; dates differ by fund.

TLSI insider transactions

latest 14
TriSalus Life Sciences, Inc. insider transactions
DateNameTransactionPriceSharesValue
2026-03-17Mary T SzelaSell$3.8515,944$61,384
2026-03-16Bryan F CoxSell$4.12579$2,385
2026-03-16Jodi DevlinSell$4.12273$1,125
2026-03-16Richard MarshakSell$4.12419$1,726
2026-03-12Bryan F CoxSell$4.091,467$6,000
2026-03-12Jodi DevlinSell$4.091,772$7,247
2026-03-12Richard MarshakSell$4.091,589$6,499
2026-03-11Bryan F CoxSell$4.131,138$4,700
2026-03-11Jodi DevlinSell$4.131,162$4,799
2026-03-11Mary T SzelaSell$4.134,358$17,999
2026-03-11Richard MarshakSell$4.131,449$5,984
2025-05-19Bryan F CoxSell$5.184,764$24,678
2025-05-19Jodi DevlinSell$5.184,764$24,678
2025-05-19Richard MarshakSell$5.186,597$34,172

Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.

TLSI shares outstanding

Shares outstanding

Year-end shares outstanding, adjusted for splits.

Who owns TLSI

Institutional investors own 35.7% of TriSalus Life Sciences's shares and insiders 33.96%. The largest holder is First Light Asset Management, LLC with 10.64% of the shares (6.6M), as of June 30, 2026. Among the top 20 institutions, 15 added shares and 4 reduced their stake in the latest filings. Short interest is 7.17% of the float, or 7.57 days of average trading volume. The share count rose 680.7% since 2020.

Related: TLSI analyst forecast, TLSI key metrics. See the TLSI stock overview for the latest quote and news.

TLSI ownership FAQ

Who owns the most TriSalus Life Sciences stock?

The largest shareholders of TriSalus Life Sciences are First Light Asset Management, LLC (10.64%), BlackRock Inc (4.32%), Nantahala Capital Management, LLC (3.25%), Vanguard Capital Management, LLC (2.81%), HPM Partners LLC (2.60%).

What percentage of TriSalus Life Sciences is owned by institutions?

Institutions hold 35.7% of TriSalus Life Sciences's shares outstanding; insiders hold 33.96%.

Which funds own TriSalus Life Sciences?

The largest fund holders of TriSalus Life Sciences are Vanguard MStar Total Stk Mkt Idx Invest (1.85%), iShares Russell 2000 ETF (1.82%), Fidelity Small Cap Index (0.85%), iShares Russell 2000 Growth ETF (0.68%), Vanguard Russell 2000 ETF (0.42%).

What is TriSalus Life Sciences's short interest?

3.3M shares of TriSalus Life Sciences were sold short, 7.17% of the float; at the average daily volume it would take 7.57 days to cover.

Are insiders buying or selling TriSalus Life Sciences?

Of the latest 14 reported insider transactions in TriSalus Life Sciences (since May 19, 2025), 0 were purchases and 14 were sales.

How many shares of TriSalus Life Sciences are outstanding?

TriSalus Life Sciences has 61.6M shares outstanding, of which 49.8M are in the public float.

Medical Devices: ownership